Oxygen therapy, the process whereby concentrated oxygen is regularly fed through the nose of a patient, may help the eyesight of diabetic patients suffering from macular oedema a new study concludes. Macular oedema is a dangerous swelling at the rear of the eye due to fluid build-up. In many cases it can severely affect the vision.
The study was carried out by scientists at the John Hopkins University in Baltimore and the National Eye Institute. The study concentrated on five diabetic patients, all of whom were suffering from severe macular oedema. They each breathed oxygen over a three month period, and were given stationary oxygen tanks to use in their own homes. The patients had all had laser treatment for the oedema, with all but one of their eyes failing to respond. Each patient had oxygen delivered to their noses at the rate of four litres per minute.
The results were extremely positive, researchers said. Fluid build-up was reduced, and the swelling that caused macular oedema declined. In some cases, the central vision of the patients improved. Researchers believe that the successful oxygen therapy could be combined with laser treatment to provide a more effective regimen for patients.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…